![Wills Hughes-Wilson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Wills Hughes-Wilson
Corporate Officer/Principal chez MEREO BIOPHARMA GROUP PLC
Fortune : 119 191 $ au 31/05/2024
Postes actifs de Wills Hughes-Wilson
Sociétés | Poste | Début | Fin |
---|---|---|---|
MEREO BIOPHARMA GROUP PLC | Corporate Officer/Principal | 01/03/2018 | - |
Historique de carrière de Wills Hughes-Wilson
Anciens postes connus de Wills Hughes-Wilson
Sociétés | Poste | Début | Fin |
---|---|---|---|
SWEDISH ORPHAN BIOVITRUM AB | Public Communications Contact | 04/07/2012 | 01/01/2018 |
Conseiller Juridique Général | 01/02/2012 | 04/07/2012 | |
Corporate Officer/Principal | 01/02/2012 | 01/01/2018 | |
Genzyme Therapeutics Ltd.
![]() Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - | - |
European Biopharmaceutical Enterprises
![]() European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Directeur/Membre du Conseil | - | - |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Formation de Wills Hughes-Wilson
University of Durham | Graduate Degree |
Statistiques
Internationale
Royaume-Uni | 4 |
Suède | 2 |
Etats-Unis | 2 |
Opérationnelle
Corporate Officer/Principal | 4 |
Public Communications Contact | 1 |
General Counsel | 1 |
Sectorielle
Health Technology | 6 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
MEREO BIOPHARMA GROUP PLC | Health Technology |
Entreprise privées | 3 |
---|---|
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
European Biopharmaceutical Enterprises
![]() European Biopharmaceutical Enterprises BiotechnologyHealth Technology European Biopharmaceutical Enterprises develops biological products. The private company is based in Brussels, Belgium. | Health Technology |
Genzyme Therapeutics Ltd.
![]() Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Wills Hughes-Wilson
- Expérience